BOCA RATON, Fla., March 28, 2018 -- Saxena White P.A. has filed a securities fraud class action lawsuit in the United States District Court of Minnesota against Patterson Companies, Inc. (“Patterson” or the “Company”) (NASDAQ:PDCO) on behalf of investors who purchased or otherwise acquired the common stock of the Company between June 26, 2015 and February 28, 2018, inclusive (the “Class Period”).
Patterson is one of the nation’s only full-service distributors of dental products. The Company distributes its products mainly through two subsidiaries—Patterson Dental and Patterson Animal Health.
The Complaint asserts claims for violations of the Securities Exchange Act of 1934. The Complaint alleges that, throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
Specifically, Defendants allegedly made false and/or misleading statements and/or failed to disclose that: (1) Defendants were engaged in a fraudulent and illegal price-fixing conspiracy; (2) the Company’s revenue and earnings were fraudulently inflated by the illegal scheme; (3) the scheme was aimed at prohibiting sales to and price negotiations by group purchasing organizations (“GPOs”) that represented small and independent dental practices; (4) as a result of the foregoing, Defendants’ statements about Patterson’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
You may obtain a copy of the Complaint and join the class action at www.saxenawhite.com.
If you purchased Patterson shares between June 26, 2015 and February 28, 2018, you may contact Lester Hooker ([email protected]) at Saxena White P.A. to discuss your rights and interests.
If you purchased Patterson securities during the Class Period of June 26, 2015 through February 28, 2018 and wish to apply to be the lead plaintiff in this action, a motion on your behalf must be filed with the Court by no later than May 29, 2018. You may contact Saxena White P.A. to discuss your rights regarding the appointment of lead plaintiff and your interest in the class action. Please note that you may also retain counsel of your choice and need not take any action at this time to be a class member.
Saxena White P.A., with offices in Florida, New York, and Massachusetts, concentrates its practice on prosecuting securities fraud and complex class actions on behalf of institutions and individuals. Currently serving as lead counsel in numerous securities fraud class actions nationwide, the firm has recovered hundreds of millions of dollars on behalf of injured investors and is active in major litigation pending in federal and state courts throughout the United States.
CONTACT INFORMATION
Lester R. Hooker, Esq.
[email protected]
Saxena White P.A.
150 East Palmetto Park Road, Suite 600
Boca Raton, FL 33432
Tel: (561) 206-6708
Fax: (866) 290-1291
www.saxenawhite.com


Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
Trump Urges Exxon, Chevron to Cut Gas Prices After Record Oil Profits
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Apple Restores Telegram to App Store After Content Policy Violation
Telegram Restored on Apple App Store After Temporary Removal
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves 



